Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life
Not Applicable
Completed
- Conditions
- Low Anterior Resection SyndromeRectal Cancer
- Interventions
- Behavioral: LARS score/ EORTC QLQ C30
- Registration Number
- NCT06059170
- Lead Sponsor
- University Hospital, Ghent
- Brief Summary
Quality of life and risk factors for developing major LARS are explored. Therapeutic options were explored in the cohort experiencing major LARS
- Detailed Description
Quality of life and risk factors for developing major LARS are explored using the EORTC QLQ C30. Therapeutic options were explored in the cohort experiencing major LARS
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 187
Inclusion Criteria
- low anterior resection for rectal cancer between 2006-2016
- Adults
Exclusion Criteria
- abdomino perineal resection
- patients who do not understand Dutch
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description QOL, risk factor and therapeutic options LARS score/ EORTC QLQ C30 questionnaires
- Primary Outcome Measures
Name Time Method Assessment QoL up to 10 years after rectal resection Assessments using questionnaire European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ C30)
frequencies of therapeutic options to manage LARS up to 10 years after rectal resection Self developed questionaire to determine what therapeutic options were used to manage LARS
Frequency of LARS up to 10 years after rectal resection Assessment of LARS using validated LARS Score
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University hospital Ghent
🇧🇪Ghent, Oost-Vlaanderen, Belgium